Rhythm Pharmaceuticals (RYTM) Earnings Date, Estimates & Call Transcripts $64.41 +0.40 (+0.62%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$64.39 -0.02 (-0.04%) As of 05/5/2025 05:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Rhythm Pharmaceuticals Earnings Summary Upcoming Earnings DateMay. 7Before Market OpensEstimatedConsensus EPS (Feb. 26) -$0.69 Actual EPS (Feb. 26) -$0.72 Missed By -$0.03 Actual Revenue (Feb. 26) $41.83MRhythm Pharmaceuticals released Q4 2024 earnings on February 26, 2025, reporting an EPS of -$0.72, which missed analysts' consensus estimates of -$0.69 by $0.03. Quarterly revenue was reported to be $41.83 million, above analysts' expectations of $38.48 million. With a trailing EPS of -$4.35, Rhythm Pharmaceuticals' earnings are expected to grow next year, from ($4.32) to ($2.58) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Annual Report (10-K) Slide Deck Press Release (8-K)RYTM Upcoming EarningsRhythm Pharmaceuticals' Q1 2025 earnings is scheduled for Wednesday, May 7, 2025, with a conference call scheduled at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get Rhythm Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rhythm Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRYTM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RYTM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Rhythm Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20251-$0.74-$0.74-$0.74Q2 20252-$0.72-$0.47-$0.60Q3 20252-$0.68-$0.59-$0.64Q4 20252-$0.72-$0.39-$0.56 FY 2025 7 -$2.86 -$2.19 -$2.53 Q1 20261-$0.60-$0.60-$0.60Q2 20261-$0.40-$0.40-$0.40Q3 20261-$0.31-$0.31-$0.31Q4 20261-$0.18-$0.18-$0.18 Rhythm Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/7/2025(Estimated)-------2/26/2025Q4 2024-$0.69-$0.72 -$0.03-$0.72$38.48M$41.83M11/5/2024Q3 2024-$0.80-$0.73+$0.07-$0.73$32.52M$33.20M8/6/2024Q2 2024-$0.71-$0.55+$0.16-$0.55$28.79M$29.08M5/7/2024Q1 2024-$2.34-$2.35 -$0.01-$2.35$26.90M$26.00M2/22/2024Q4 2023-$0.70-$0.70--$0.70$25.38M$24.23M11/7/2023Q3 2023-$0.76-$0.76--$0.76$22.18M$22.50M8/1/2023Q2 2023-$0.80-$0.82 -$0.02-$0.82$15.03M$19.20M Rhythm Pharmaceuticals Earnings - Frequently Asked Questions When is Rhythm Pharmaceuticals's earnings date? Rhythm Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based off last year's report dates. Learn more on RYTM's earnings history. Did Rhythm Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Rhythm Pharmaceuticals (NASDAQ:RYTM) missed the analysts' consensus estimate of ($0.69) by $0.03 with a reported earnings per share (EPS) of ($0.72). Learn more on analysts' earnings estimate vs. RYTM's actual earnings. How can I listen to Rhythm Pharmaceuticals's earnings conference call? The conference call for Rhythm Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Rhythm Pharmaceuticals's conference call transcript? The conference call transcript for Rhythm Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Rhythm Pharmaceuticals generate each year? Rhythm Pharmaceuticals (NASDAQ:RYTM) has a recorded annual revenue of $130.13 million. How much profit does Rhythm Pharmaceuticals generate each year? Rhythm Pharmaceuticals (NASDAQ:RYTM) has a recorded net income of -$184.68 million. RYTM has generated -$4.35 earnings per share over the last four quarters. What is Rhythm Pharmaceuticals's EPS forecast for next year? Rhythm Pharmaceuticals's earnings are expected to grow from ($4.32) per share to ($2.58) per share in the next year. More Earnings Resources from MarketBeat Related Companies ITCI Earnings Date GMAB Earnings Date RDY Earnings Date MRNA Earnings Date ASND Earnings Date VTRS Earnings Date QGEN Earnings Date ROIV Earnings Date RVMD Earnings Date LNTH Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan This page (NASDAQ:RYTM) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rhythm Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RYTM Stock Free RYTM Stock Alerts